PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Panacea Biotec Ltd. ('PBL') is delighted to announce the landmark collaboration with Refana Inc. USA for Covid-19 vaccine which will enable global development, manufacturing and distribution of the Covid-19 vaccine. Under the collaboration, Panacea Biotec is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc. USA to make Covid-19 vaccine widely accessible around the world in an equitable manner through a Joint Venture company to be based in Ireland. A copy of the Press Release titled 'Panacea Biotec and Refana announce landmark collaboration for Covid-19 vaccine' being issued to the media, etc. in this regard is enclosed for your kind reference and record please.10-06-2020